Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Turnaround Potential
2940.0000 -0.10 (-0.00%)
NSE Feb 17, 2026 14:38 PM
Volume: 42,706
 

logo
Ajanta Pharma Ltd.
29 Jul 2025
buy
by BOB Capital Markets Ltd.
Target: 2783 | Target met
BOB Capital Markets Ltd.
Earnings were in line with our estimates with sales /EBITDA/PAT reported 1%/-2.7%/3% above estimates
 
ICICI Direct increased Buy price target of Ajanta Pharma Ltd. to 3270.0 on 01 Feb, 2026.
More from Ajanta Pharma Ltd.
Recommended
Market trades flat, Alkem Laboratories gets Form 483 with six observations from the US FDA
Trendlyne Marketwatch | 17 Feb 2026, 02:22PM
Big-ticket IPOs are back: Two mainline debuts in the primary market
| 16 Feb 2026, 05:13PM
Ajanta Pharma disputes ET article on FDA import alert
| 24 Jan 2017